N. Locopo

Phase II randomized trial on dose-escalated sorafenib (S) versus best supportive care (BSC) in patients with advanced hepatocellular carcinoma (HCC) with disease progression on prior S treatment.

R. Labianca, C. Porta, C. Boni, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Behaviour of metastasis in relation to vascular index in patients with node-positive breast cancer treated with adjuvant tamoxifen

Elia Biganzoli, Patrizia Boracchi, Giampietro Gasparini, 2004, Clinical & Experimental Metastasis.

Clinical significance of angiogenic factors in breast cancer

G. Gasparini, M. Fanelli, N. Locopo, 2004, Breast Cancer Research and Treatment.

Assessment of Tumor Vascularization: Immunohistochemical and Non-Invasive Methods

G. Gasparini, M. Fanelli, D. Gattuso, 1999, The International journal of biological markers.

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis.

R. Labianca, C. Porta, C. Boni, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis.

R. Labianca, C. Porta, C. Boni, 2013 .

Rationale for the use of gemcitabine in breast cancer (Review).

V. Lorusso, M. de Lena, N. Silvestris, 2004, International Journal of Oncology.